Dianthus Therapeutics director Simon Read disposes of common shares worth $326,148.9
DNTH•Director exercises options and sells shares
- Dianthus Therapeutics director Simon Read exercised stock options for 2,778 common shares at USD 18.36 on Aug. 19, 2026.
- Read sold 2,778 common shares at a weighted average USD 117.55 on the same day.
- His direct common stock ownership fell to zero following the transactions.
